Albuterol/budesonide (AIRSUPRA®) clinical trials

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

This study looks at how well a new asthma medicine, tezepelumab, works to control severe asthma while patients try to reduce their regular asthma inhaler use. It aims to see if patients can stay well on less medicine.